111 related articles for article (PubMed ID: 34265180)
1. Validating cell-free DNA from supernatant for molecular diagnostics on cytology specimens.
Perrone ME; Alvarez R; Vo TT; Chung MW; Chhieng DC; Paulson VA; Colbert BG; Q Konnick E; Huang EC
Cancer Cytopathol; 2021 Dec; 129(12):956-965. PubMed ID: 34265180
[TBL] [Abstract][Full Text] [Related]
2. Comparison of cytocentrifugation supernatant fluid and formalin-fixed paraffin-embedded tissue for targeted next-generation sequencing.
Janaki N; Harbhajanka A; Michael CW; Bomeisl P; Wasman J; Atchley M; Miskiewicz K; Alouani D; Sadri N
Cancer Cytopathol; 2019 May; 127(5):297-305. PubMed ID: 30933438
[TBL] [Abstract][Full Text] [Related]
3. Validation of a DNA-Based Next-Generation Sequencing Test for Molecular Diagnostic Variant and Fusion Detection in Formalin-Fixed, Paraffin-Embedded Tissue Specimens and Liquid Biopsy Plasma/Cell-Free DNA Samples.
Werner TV; Kock S; Weber I; Kayser G; Werner M; Lassmann S
J Mol Diagn; 2022 Jul; 24(7):784-802. PubMed ID: 35787794
[TBL] [Abstract][Full Text] [Related]
4. Performance of non-formalin fixed paraffin embedded samples in hybrid capture and amplicon next-generation sequencing panels.
Meireles SI; Cruz MV; de Godoy CD; de Testagrossa L
Diagn Cytopathol; 2024 Mar; 52(3):171-182. PubMed ID: 38124281
[TBL] [Abstract][Full Text] [Related]
5. NGS Analysis of Liquid Biopsy (LB) and Formalin-Fixed Paraffin-Embedded (FFPE) Melanoma Samples Using Oncomine™ Pan-Cancer Cell-Free Assay.
Olbryt M; Rajczykowski M; Bal W; Fiszer-Kierzkowska A; Cortez AJ; Mazur M; Suwiński R; Widłak W
Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356096
[TBL] [Abstract][Full Text] [Related]
6. Multiplatform comparison of molecular oncology tests performed on cytology specimens and formalin-fixed, paraffin-embedded tissue.
Gailey MP; Stence AA; Jensen CS; Ma D
Cancer Cytopathol; 2015 Jan; 123(1):30-9. PubMed ID: 25186473
[TBL] [Abstract][Full Text] [Related]
7. Targeted deep sequencing of cell-free DNA in serous body cavity fluids with malignant, suspicious, and benign cytology.
Yang SR; Mooney KL; Libiran P; Jones CD; Joshi R; Lau HD; Stehr H; Berry GJ; Zehnder JL; Long SR; Kong CS; Kunder CA
Cancer Cytopathol; 2020 Jan; 128(1):43-56. PubMed ID: 31751001
[TBL] [Abstract][Full Text] [Related]
8. Targeted deep sequencing of effusion cytology samples is feasible, informs spatiotemporal tumor evolution, and has clinical and diagnostic utility.
Leichsenring J; Volckmar AL; Kirchner M; Kazdal D; Kriegsmann M; Stögbauer F; Bockmayr T; Klauschen F; Herth FJF; Penzel R; Warth A; Schirmacher P; Endris V; Stenzinger A
Genes Chromosomes Cancer; 2018 Feb; 57(2):70-79. PubMed ID: 29044880
[TBL] [Abstract][Full Text] [Related]
9. Comparison of whole-exome sequencing of matched fresh and formalin fixed paraffin embedded melanoma tumours: implications for clinical decision making.
De Paoli-Iseppi R; Johansson PA; Menzies AM; Dias KR; Pupo GM; Kakavand H; Wilmott JS; Mann GJ; Hayward NK; Dinger ME; Long GV; Scolyer RA
Pathology; 2016 Apr; 48(3):261-6. PubMed ID: 27020503
[TBL] [Abstract][Full Text] [Related]
10. Next-generation sequencing of RNA and DNA isolated from paired fresh-frozen and formalin-fixed paraffin-embedded samples of human cancer and normal tissue.
Hedegaard J; Thorsen K; Lund MK; Hein AM; Hamilton-Dutoit SJ; Vang S; Nordentoft I; Birkenkamp-Demtröder K; Kruhøffer M; Hager H; Knudsen B; Andersen CL; Sørensen KD; Pedersen JS; Ørntoft TF; Dyrskjøt L
PLoS One; 2014; 9(5):e98187. PubMed ID: 24878701
[TBL] [Abstract][Full Text] [Related]
11. Implementation of next generation sequencing technology for somatic mutation detection in routine laboratory practice.
Giardina T; Robinson C; Grieu-Iacopetta F; Millward M; Iacopetta B; Spagnolo D; Amanuel B
Pathology; 2018 Jun; 50(4):389-401. PubMed ID: 29752127
[TBL] [Abstract][Full Text] [Related]
12. Performance of amplicon-based next generation DNA sequencing for diagnostic gene mutation profiling in oncopathology.
Sie D; Snijders PJ; Meijer GA; Doeleman MW; van Moorsel MI; van Essen HF; Eijk PP; Grünberg K; van Grieken NC; Thunnissen E; Verheul HM; Smit EF; Ylstra B; Heideman DA
Cell Oncol (Dordr); 2014 Oct; 37(5):353-61. PubMed ID: 25209392
[TBL] [Abstract][Full Text] [Related]
13. Cytology smears as excellent starting material for next-generation sequencing-based molecular testing of patients with adenocarcinoma of the lung.
Velizheva NP; Rechsteiner MP; Wong CE; Zhong Q; Rössle M; Bode B; Moch H; Soltermann A; Wild PJ; Tischler V
Cancer Cytopathol; 2017 Jan; 125(1):30-40. PubMed ID: 27636102
[TBL] [Abstract][Full Text] [Related]
14. Whole exome sequencing (WES) on formalin-fixed, paraffin-embedded (FFPE) tumor tissue in gastrointestinal stromal tumors (GIST).
Astolfi A; Urbini M; Indio V; Nannini M; Genovese CG; Santini D; Saponara M; Mandrioli A; Ercolani G; Brandi G; Biasco G; Pantaleo MA
BMC Genomics; 2015 Nov; 16():892. PubMed ID: 26531060
[TBL] [Abstract][Full Text] [Related]
15. Targeted Next Generation Sequencing as a Reliable Diagnostic Assay for the Detection of Somatic Mutations in Tumours Using Minimal DNA Amounts from Formalin Fixed Paraffin Embedded Material.
de Leng WW; Gadellaa-van Hooijdonk CG; Barendregt-Smouter FA; Koudijs MJ; Nijman I; Hinrichs JW; Cuppen E; van Lieshout S; Loberg RD; de Jonge M; Voest EE; de Weger RA; Steeghs N; Langenberg MH; Sleijfer S; Willems SM; Lolkema MP
PLoS One; 2016; 11(2):e0149405. PubMed ID: 26919633
[TBL] [Abstract][Full Text] [Related]
16. BRAF mutation testing with a rapid, fully integrated molecular diagnostics system.
Janku F; Claes B; Huang HJ; Falchook GS; Devogelaere B; Kockx M; Bempt IV; Reijans M; Naing A; Fu S; Piha-Paul SA; Hong DS; Holley VR; Tsimberidou AM; Stepanek VM; Patel SP; Kopetz ES; Subbiah V; Wheler JJ; Zinner RG; Karp DD; Luthra R; Roy-Chowdhuri S; Sablon E; Meric-Bernstam F; Maertens G; Kurzrock R
Oncotarget; 2015 Sep; 6(29):26886-94. PubMed ID: 26330075
[TBL] [Abstract][Full Text] [Related]
17. Suitability of melanoma FFPE samples for NGS libraries: time and quality thresholds for downstream molecular tests.
Millán-Esteban D; Reyes-García D; García-Casado Z; Bañuls J; López-Guerrero JA; Requena C; Rodríguez-Hernández A; Traves V; Nagore E
Biotechniques; 2018 Aug; 65(2):79-85. PubMed ID: 30091391
[TBL] [Abstract][Full Text] [Related]
18. Technical in-depth comparison of two massive parallel DNA-sequencing methods for formalin-fixed paraffin-embedded tissue from victims of sudden cardiac death.
Adolfsson E; Qvick A; Gréen H; Kling D; Gunnarsson C; Jonasson J; Gréen A
Forensic Sci Int Genet; 2021 Jul; 53():102522. PubMed ID: 33945952
[TBL] [Abstract][Full Text] [Related]
19. Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing.
Wong SQ; Li J; Tan AY; Vedururu R; Pang JM; Do H; Ellul J; Doig K; Bell A; MacArthur GA; Fox SB; Thomas DM; Fellowes A; Parisot JP; Dobrovic A;
BMC Med Genomics; 2014 May; 7():23. PubMed ID: 24885028
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of different massive parallel sequencing platforms for mutation profiling in formalin-fixed and paraffin-embedded samples].
Jiang RR; Wang YJ; Teng XD; Xiao L; Bu H; Ye F
Zhonghua Bing Li Xue Za Zhi; 2018 Aug; 47(8):591-596. PubMed ID: 30107663
[No Abstract] [Full Text] [Related]
[Next] [New Search]